Related Experiment Video

Updated: Mar 28, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.7K

Expression of cyclin A in A549 cell line after treatment with arsenic trioxide

Agnieszka Żuryń1, Adrian Krajewski1, Anna Litwiniec2

  • 1Department of Histology and Embryology, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Faculty of Medicine, Karlowicza 24, 85-092 Bydgoszcz, Poland.

Postepy Higieny I Medycyny Doswiadczalnej (Online)
|December 17, 2015
PubMed
Abstract

Insights

Arsenic trioxide (ATO) alters cyclin A expression and localization in A549 lung cancer cells. Low cyclin A may contribute to ATO resistance, impacting cell cycle regulation and treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Arsenic trioxide (ATO) is an established treatment for acute promyelocytic leukemia (AML).
  • Emerging evidence suggests ATO's potential as an anticancer agent for solid tumors.
  • The precise mechanisms of ATO's effects on cell cycle regulators remain largely unknown.

Purpose of the Study:

  • To investigate the impact of arsenic trioxide on cyclin A expression and its cellular localization.
  • To analyze the effects of ATO on cell cycle distribution and apoptosis in A549 lung cancer cells.

Main Methods:

  • Light and transmission electron microscopy for morphological analysis.
  • Immunofluorescence to determine cyclin A localization.
  • Image-based cytometry for apoptosis and cell cycle assessment.
  • Real-time PCR for quantifying cyclin A mRNA expression.

Main Results:

  • Arsenic trioxide treatment led to increased cytoplasmic localization of cyclin A.
  • Reduced cyclin A mRNA expression was observed at higher ATO concentrations (10 and 15 μM).
  • ATO induced cell cycle redistribution, with enrichment in G0/G1 at low doses and G2/M at higher doses.
  • Apoptosis levels remained low across tested ATO concentrations.

Conclusions:

  • Low cyclin A expression in A549 cells may be a factor in arsenic trioxide resistance.
  • Observed changes in cyclin A expression and distribution correlate with altered cell cycle regulation.
  • These findings suggest a potential mechanism influencing arsenic trioxide treatment efficacy in solid tumors.

More Related Videos

In Vitro Scratch Assay to Demonstrate Effects of Arsenic on Skin Cell Migration09:24

In Vitro Scratch Assay to Demonstrate Effects of Arsenic on Skin Cell Migration

Published on: February 23, 2019

24.2K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.7K

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
The Cell Cycle Control System02:11

The Cell Cycle Control System

The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...
14.9K